1. Platelets activation is associated with elevated plasma mitochondrial DNA during cardiopulmonary bypass
    Chaoyi Qin et al, 2016, Journal of Cardiothoracic Surgery CrossRef
  2. Targeting the proinflammatory cytokine tumor necrosis factor-α to alleviate cardiopulmonary bypass-induced lung injury (Review)
    MINGXIN GAO et al, 2015, Molecular Medicine Reports CrossRef
  3. cfDNA correlates with endothelial damage after cardiac surgery with prolonged cardiopulmonary bypass and amplifies NETosis in an intracellular TLR9-independent manner
    Adnana Paunel-Görgülü et al, 2017, Scientific Reports CrossRef
  4. Ischemia/reperfusion injury: Effect of simultaneous inhibition of plasma cascade systems versus specific complement inhibition
    Claudia Duehrkop et al, 2014, Biochemical Pharmacology CrossRef
  5. Does heart surgery change the capacity of α1-antitrypsin to inhibit the ATP-induced release of monocytic interleukin-1β? A preliminary study
    A. Agné et al, 2020, International Immunopharmacology CrossRef
  6. Whole Blood Reactivity to Viral and Bacterial Pathogens after Non-Emergent Cardiac Surgery during the Acute and Convalescence Periods Demonstrates a Distinctive Profile of Cytokines Production Compared to the Preoperative Baseline in Cohort of 108 Patients, Suggesting Immunological Reprogramming during the 28 Days Traditionally Recognized as the Post-Surgical Recovery Period
    Krzysztof Laudanski et al, 2023, Biomedicines CrossRef
  7. Weighted gene co-expression identification of CDKN1A as a hub inflammation gene following cardiopulmonary bypass in children with congenital heart disease
    Huan Chen et al, 2022, Frontiers in Surgery CrossRef
  8. Raised IL-2 and TNF-α concentrations are associated with postoperative delirium in patients undergoing coronary-artery bypass graft surgery
    Jakub Kazmierski et al, 2014, International Psychogeriatrics CrossRef
  9. Differences of early immunological responses in on-pump versus off-pump cardiac surgery
    Sven Lehmann et al, 2019, Perfusion CrossRef
  10. Recombinant human soluble thrombomodulin prevents acute lung injury in a rat cardiopulmonary bypass model
    Shingo Hirao et al, 2017, The Journal of Thoracic and Cardiovascular Surgery CrossRef
  11. Electroacupuncture Pretreatment Attenuates Acute Lung Injury Through α7 Nicotinic Acetylcholine Receptor-Mediated Inhibition of HMGB1 Release in Rats After Cardiopulmonary Bypass
    Zhankui Wang et al, 2018, Shock CrossRef
  12. Dexamethasone Preconditioning in Cardiac Procedures Reduces Decreased Antithrombin Activity and Is Associated to Beneficial Outcomes: Role of Endothelium
    Vicente Muedra et al, 2018, Frontiers in Pharmacology CrossRef
  13. HMGB1 in health and disease
    Rui Kang et al, 2014, Molecular Aspects of Medicine CrossRef
  14. Variation of perioperative plasma mitochondrial DNA correlate with peak inflammatory cytokines caused by cardiac surgery with cardiopulmonary bypass
    Chaoyi Qin et al, 2015, Journal of Cardiothoracic Surgery CrossRef
  15. The role and mechanism of the annexin A1 peptide Ac2‐26 in rats with cardiopulmonary bypass lung injury
    Jiyang Xu et al, 2021, Basic & Clinical Pharmacology & Toxicology CrossRef
  16. Markers of early atherosclerosis, oxidative stress and inflammation in patients with acromegaly
    Cigdem Ozkan et al, 2015, Pituitary CrossRef
  17. Alpha7 Nicotine Acetylcholine Receptor Agonist PNU-282987 Attenuates Acute Lung Injury in a Cardiopulmonary Bypass Model in Rats
    Jiaxi Ge et al, 2017, Shock CrossRef